News & Events

Our news posts are an easy way to keep up-to-date with all our latest developments. View the event posts to stay informed of all our upcoming events and activities.

Characterisation of the antinociceptive effect of baricitinib in the collagen antibody-induced arthritis mouse model

We are happy to announce the publication of “Characterisation of the antinociceptive effect of baricitinib in the collagen antibody-induced arthritis...

FamilieSCN2A Foundation and Cellectricon Announce Strategic Partnership

We are honored to have been selected as a partner to the FamilieSCN2A Foundation and to support their work to...

Cellectricon joins SwedenBIO, a non-profit association for Life Science in Sweden

Cellectricon, a services provider dedicated to advancing drug discovery and research in neuroscience, has become a member of SwedenBIO, a...

Sign up to get news & events updates from Cellectricon

Cellectricon receives EcoVadis Sustainability Rating

Cellectricon, a services provider dedicated to advancing drug discovery and research in neuroscience, has been awarded a Bronze Medal by...

Development of human in vitro models for the study of pain

In September, Cellectricon welcomed our new coworker Andrea Lovincic Babic to the team. Andrea will carry out her PhD project...

A PhD position in pain research available in collaboration with Karolinska Institutet

We are looking for a new colleague for an open position as PhD fellow in the EU-funded Marie Skłodowska-Curie Actions...

Sign up to get news & events updates from Cellectricon

Cellectricon and Fluicell initate collaboration to validate tissue-based in vitro models

We’re excited to be working with Fluicell AB and support their development of bioprinted tissues for use in research and...

Cellectricon launches Neuroinflammation Research Service

MÖLNDAL, SWEDEN Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, has launched the Neuroinflammation Research Service module. Established...

Dr. Jonathan Levenson joins Cellectricon’s advisory board

Cellectricon has appointed Dr. Jonathan Levenson, Chief Scientific Officer at FireCyte Therapeutics, to its Scientific Advisory Board. Dr. Levenson brings...

1 2 3 … 8